id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6784-0014,FDA,FDA-2017-D-6784,Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers,Other,Guidance,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,,2024-11-07T00:34:15Z,,1,0,0900006484e1b788
FDA-2017-D-6784-0013,FDA,FDA-2017-D-6784,Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers; Guidance for Industry; Availability,Notice,Notice of Availability,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,,2021-11-09T17:41:05Z,2021-24073,0,0,0900006484e17ebf